Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
831.3 USD | +1.33% | +2.95% | +42.60% |
06-03 | Eli Lilly: encouraging data for olomorasib | CF |
06-03 | Structure Therapeutics' obesity drug meets main goal in mid-stage study | RE |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.60% | 739B | |
+32.34% | 598B | |
-5.74% | 353B | |
+17.79% | 318B | |
+3.37% | 285B | |
+16.47% | 240B | |
+9.26% | 210B | |
-5.07% | 206B | |
+6.74% | 164B | |
+1.81% | 162B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Transcript : Eli Lilly and Company, Q2 2022 Earnings Call, Aug 04, 2022